Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its second quarter 2014 and recent business activities.
“Demand for LINZESS grew 36% in the second quarter supported by the initiation of our direct-to-consumer efforts, which drove net product sales higher despite a two week decrease in wholesaler inventory during the quarter.
Help employers find you! Check out all the jobs and post your resume.
